![Scott Dahlbeck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Dahlbeck
Founder at KIROMIC BIOPHARMA, INC.
Net worth: 182 186 $ as of 2024-05-30
Profile
Scott Dahlbeck is the founder and currently holds the position of Chief of Staff at Kiromic Biopharma, Inc., a company he founded in 2006.
He is also the founder and currently holds the position of President & Chief Medical Officer at Kiromic, Inc., a company he founded in 2013.
Dr. Dahlbeck has a doctorate degree from the University of Nebraska Medical Center and The University of Texas Health Science Center at Houston.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
KIROMIC BIOPHARMA, INC.
3.69% | 2024-05-14 | 56,933 ( 3.69% ) | 182 186 $ | 2024-05-30 |
Scott Dahlbeck active positions
Companies | Position | Start |
---|---|---|
KIROMIC BIOPHARMA, INC. | Founder | 2006-08-05 |
Kiromic, Inc.
![]() Kiromic, Inc. Medical/Nursing ServicesHealth Services Kiromic, Inc. is a biotech company that has discovered a breakthrough technology called the Diamond Artificial Intelligence platform. It serves as the foundation for Kiromic’s new drug discoveries through novel target identification. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck in 2013 and is headquartered in Houston, TX. | Founder | 2012-12-31 |
Training of Scott Dahlbeck
University of Nebraska Medical Center | Doctorate Degree |
The University of Texas Health Science Center at Houston | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
KIROMIC BIOPHARMA, INC. | Health Technology |
Private companies | 1 |
---|---|
Kiromic, Inc.
![]() Kiromic, Inc. Medical/Nursing ServicesHealth Services Kiromic, Inc. is a biotech company that has discovered a breakthrough technology called the Diamond Artificial Intelligence platform. It serves as the foundation for Kiromic’s new drug discoveries through novel target identification. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck in 2013 and is headquartered in Houston, TX. | Health Services |
- Stock Market
- Insiders
- Scott Dahlbeck